Utilising the Benefit Risk Assessment of Vaccines (BRAVE) toolkit to evaluate the benefits and risks of Vaxzevria in the EU: a population-based study
- Hector Gonzalez Dorta
- , Johan Verbeeck
- , Jonas Crevecoeur
- , Daniel R Morales
- , Neilshan Loedy
- , Catherine Cohet
- , Lander Willem
- , Geert Molenberghs
- , Niel Hens
- , Xavier Kurz
- , Chantal Quinten (Lead / Corresponding author)
- , Steven Abrams
Research output: Contribution to journal › Article › peer-review
3
Link opens in a new tab
Citations
(Scopus)
57
Downloads
(Pure)